First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 0.38 USD 1.31% Market Closed
Updated: Mar 29, 2024

Yield10 Bioscience Inc
Capital Expenditures

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Yield10 Bioscience Inc
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Yield10 Bioscience Inc
NASDAQ:YTEN
Capital Expenditures
$-30k
CAGR 3-Years
31%
CAGR 5-Years
6%
CAGR 10-Years
20%
Abbvie Inc
NYSE:ABBV
Capital Expenditures
$-777m
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
-5%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
$-585m
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
-12%
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
$-1.1B
CAGR 3-Years
-22%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
$-258.4m
CAGR 3-Years
0%
CAGR 5-Years
-22%
CAGR 10-Years
-18%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
$-926.4m
CAGR 3-Years
-15%
CAGR 5-Years
-19%
CAGR 10-Years
-19%

See Also

What is Yield10 Bioscience Inc's Capital Expenditures?
Capital Expenditures
-30k USD

Based on the financial report for Sep 30, 2023, Yield10 Bioscience Inc's Capital Expenditures amounts to -30k USD.

What is Yield10 Bioscience Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
20%

Over the last year, the Capital Expenditures growth was 84%. The average annual Capital Expenditures growth rates for Yield10 Bioscience Inc have been 31% over the past three years , 6% over the past five years , and 20% over the past ten years .